Tag Archives: biosimilars arthritis

Akylosing Spodylitis Treatment

FDA Approves First Biosimilar for Arthritis

The U.S. Food and Drug Administration (FDA) has approved Inflectra – a so-called biosimilar version of the biologic Remicade (infliximab) – to treat rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) as well as psoriasis and inflammatory bowel disease. It is the first biosimilar approved in the U.S. for autoimmune, inflammatory conditions, including RA, PsA and AS, and only the second biosimilar approved by the agency to date. (A drug used in cancer treatment, filgrastim-sndz, sold as Zarxio, was approved in March 2015.)
Continue reading FDA Approves First Biosimilar for Arthritis